Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed Growth (3y) (2014 - 2026)
Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -356.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -516.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -2,309.00 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4,967.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,424.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 513.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5,777.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 109.00 |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 949.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 949.00 |
| Mar 31, 2026 | -40.00 |
| Dec 31, 2025 | -183.00 |
| Sep 30, 2025 | -600.00 |
| Jun 30, 2025 | -638.00 |
| Mar 31, 2025 | -3,411.00 |
| Dec 31, 2024 | -7,878.00 |
| Sep 30, 2024 | -16,776.00 |
| Jun 30, 2024 | -14,968.00 |
| Mar 31, 2024 | -3,762.00 |
| Dec 31, 2023 | -2,338.00 |
| Sep 30, 2023 | -2,188.00 |
| Jun 30, 2023 | 898.00 |
| Mar 31, 2023 | 7,504.00 |
| Dec 31, 2022 | 29,627.00 |
| Sep 30, 2022 | 20,186.00 |
| Jun 30, 2022 | 12,239.00 |
| Mar 31, 2022 | 7,596.00 |
| Dec 31, 2021 | 9,725.00 |
| Sep 30, 2021 | 12,092.00 |